- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2014-004928-21.
Displaying page 1 of 1.
EudraCT Number: 2014-004928-21 | Sponsor Protocol Number: CINC424A2353 | Start Date*: 2016-01-27 |
Sponsor Name:Novartis Farmacéutica, S.A. | ||
Full Title: A randomized, double blind, placebo-controlled, multi-center, Phase III study investigating the efficacy and safety of ruxolitinib in Early Myelofibrosis patients with high molecular risk mutations | ||
Medical condition: Early Myelofibrosis patients with high molecular risk mutations | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) SE (Prematurely Ended) GB (Prematurely Ended) AT (Prematurely Ended) BE (Prematurely Ended) HU (Completed) GR (Completed) FR (Prematurely Ended) PT (Prematurely Ended) FI (Prematurely Ended) DK (Prematurely Ended) PL (Prematurely Ended) IT (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.